Is this an abusive relationship?

(or why I won’t be responding to another government consultation on trans healthcare).

Just weeks after having submitted an invited response (invited as an academic expert) to a government consultation on making a legal ban on puberty blockers permanent, ANOTHER government consultation on trans healthcare has today been launched.

This one is on adult trans healthcare services. There are many reasons to approach this consultation with concern. The consultation itself provides a link to the incredibly biased and prejudice-ladden letter from Dr Cass which is a driver of this current review.

I cannot even remember how many government consultations related to trans rights or trans healthcare I have completed over the past 8 years. It is far far far beyond a joke.

And each public consultation takes the same form. The new NHS adults services consultation even provides a link to an analysis and summary of responses to the 2017 consultation. Reading the executive summary of that analysis is very telling and illustrative of the problem. In the 2017 consultation, responses were divided into three groupings:

  • Current, former or prospective user of gender identity services (30.15% of respondents)
  • Individual member of the public (26.8% of respondents)
  • Clinician (16.75% of respondents)

The 2017 consultation responses summarises very succinctly the differences between these responses (worth reading on pages 2-6). In short, the current and former users of gender identity services provided detailed and meaningful suggestions on how services could be reformed and improved. Clinician respondents, who were, mostly GPs, broadly didn’t know what to do with trans people and didn’t want to have responsibility. Members of the public felt being trans was a mental disorder and wanted services to be made significantly worse for trans people. The consultation presented all of these contrasting views, with the views of actual trans people in one grouping (glossing over nuances in actual recommendations re different ways of improving trans health), while views that were ambivalent or fundamentally opposed to trans well-being and healthcare rights were given equal weighting to those of actual service users.

This pattern has then repeated time and time again since 2017.

This pattern will be repeated in this new NHS consultation. Although now the anti-trans lobby is much more organised and assertive, so I expect even more volume of anti-trans submission, including from transphobic clinicians and medical professionals, and including from those purporting to be prospective service users (or concerned family members of service users).

This pattern of public consultation for minoritized healthcare is extremely abusive.

Every consultation response is a huge amount of effort to do well. It is a significant extraction of labour from already exhausted trans people, including from those of us who are called to respond as trans-supportive researchers or on behalf of civil society.

It is abusive to ask us for consultation after consultation after consultation. Every single one we respond defensively, knowing that the purpose of the consultation is not to improve services and respect rights, but to justify an ever further roll back of those rights, and ever more severe degredation of those services.

It is abusive to ask trans folks to engage in yet another consultation where the views of those fundamentally bigoted about trans existence are given equal weight.

It is abusive full stop.

This particular consultation is where I personally draw a line. It is not acceptable.

I expect adults trans healthcare will be made worse in the coming years, building upon Cass. I expect this public consultation, including the thousands of responses from profoundly anti-trans individuals and lobby groups, will be used to justify that degregation of essential healthcare. To justify the inclusion of ever greater rights violations in our healthcare. To justify ever greater encroach into the reasons to deny care to those of us who are the wrong kind of trans.

Esteemed trans healthcare scholar Dr Ruth Pearce wrote all the way back in 2018 (about another consultation on trans health conducted about us yet without us), that “we respond not with hope or optimism, but in fear. This is the power you wield over us”.

Over the past years I have responded to more government consultations on trans topics than I can count. Every single submission I have written, not out of hope, but out of fear. Out of a feeling of responsibility to use my relative privilege to at least try and change the outcomes, to raise my voice to highlight the current injustices and the harms of abusive practice.

But we are clearly not being listened to. Time and time again we are not being listened to.

How long do we keep collaborating in the same pattern. How long do we keep gas-lighting ourselves?

Today I’m saying no.

I refuse to remain in any part of this extremely abusive relationship.

I refuse out of principle to engage in any way with a consultation that is equally interested in the views of non-service users, that does not have really basic ethical commitments to trans depathologisation, dignity and healthcare rights, that does not have trans leadership and trans power at its centre.

I refuse to respond defensively while having zero hope that my words and my time are going to change the outcome. In this case, as before, I fundamentally don’t believe my inputs will in any way change the outcome. Quite the opposite – I believe my words and my submission, alongside those of others submitted and hard-worked-on out of a feeling of responsibility to our communities, will provide the government/NHS with a veneer of respectability, that they asked and listened to all views.

Listening to all views is not good enough. I literally cannot stomach another consultation that will be written up as “here’s what trans people want, however here’s what doctors and members of the public want, so we are therefore going to make trans healthcare worse”. It is not good enough. I am out.

I’m not saying that stepping out of this consultation will be enough to change the outcome. I’m not saying there is a clear path to trans justice.

But I’m at least not going to waste my time on another heartless and fundamentally flawed process.

Today I will choose to do something better with my time.

I hope we can at some point be more coordinated and demanding, standing together in solidarity and power, saying we will not engage with processes that are fundamentally dehumanising and abusive. Most folks I know right now are too worn down by all the loses, by all the pain, by all the energy expended on heartless consultations, to have the energy and reserves to try and take back any power.

Maybe that is one of the ways forward. For now we take time, we rest, we refuse to respond defensively, we let go of the fleeting hope that our submission will be enough to change power structures that continue to inflict harm after harm.

We focus our time and energy on ways to keep ourselves and those who are suffering afloat through these tough times.

We state clearly and in unison that when the government and the NHS decide they believe in our humanity, when they have an ounce of care for justice and equality, when they recognise that anti-trans views are not welcome in consultations on our healthcare, then we have plenty of ideas to share on the meaningful reform of trans healthcare. But until that approach is made in good faith, and with trans people in positions of authority – we have better things to focus on. We focus on surviving the anti-trans hate that continues to grow in the UK, including in senior leadership in the government and NHS.

.

WPATH 2024: Part Two

On the 3rd full day of WPATH 2024, there was one session that I wanted to write up in slightly more detail, as it is very relevant to those working with or supporting trans children and young people. (My original WPATH 2024 blog is available here). The session was titled “New long-term research on adolescent gender-affirming medical care”, with 5 presenters, three from the US, and two from the Netherlands.

I wanted to share my notes on these presentations here. First a big caveat – my notes and interpretation may not be 100% correct, I have not confirmed this post with the presenters of these studies, and these studies have not yet been finalised, peer reviewed or published. Therefore, the data in this study may change before acceptance into the formal literature. At WPATH, within the trans room, there was a discussion on the challenges of knowledge that is of vital importance to trans communities and families of trans kids being paywalled behind expensive and hard to attend conferences. Recognising the very slow timelines of academic publishing, there was a discussion on a duty to share early preliminary results not only with the clinicians and researchers who are able to attend WPATH, but also with the very interested and directly affected trans and family of trans kids communities, currently trying to defend our healthcare from attack, for whom new research is most important. In the trans room at WPATH we talked about our responsibility and duty of care as trans researchers with half a foot in clinical spaces to share information with those who cannot access. As part of this commitment I’m writing this blog.  

First Dr Diane Chen (she/her) presented on trajectories for mental health in the four years following gender affirming hormone initiation. She highlighted the six existing studies that examine psycho-social outcomes in US-based trans youth receiving oestrogen or testosterone (Allen; Achille; Kuper; Tordoff; Chelliah; Chen). These studies have generally found that aspects of mental health improve following initiation of gender affirming hormones. These studies have limitations including that they only follow youth for average of one year after treatment initiation, that they only focus on (internalising) areas like anxiety or depression, and the one article (by the presenter Chen et al) that looked at individual trajectories found significant individual variation around the average change in outcomes. For that study the presenter showed graphs showing, on average, a steep improvement in appearance congruence, a shallow reduction in depression and anxiety, and a shallow improvement in positive-affect and life satisfaction over 2 years. The individual dots show significant variability, suggesting a focus on the average experience may hide difference trajectories between sub-groups. The new study being presented here aims to look at potential distinct trajectories between sub-groups.

The new study (by Chen et al, not yet published), looked at data for 217 youth, average age 16 (range 11-20), 60% trans-masc, 34% trans-femme, 4% non-binary, 80% socially transitioned at baseline, 7.6% received gender affirming care in early puberty (defined as puberty blockers at tanner 2 or 3 or HRT at tanner 3). The study looked at internalising data on (anxiety/depression), at externalising (aggression, risk taking), experiences of gender minority stress, and parental acceptance. Data were collected at baseline, year 1, year 2, year 3 and year 4 [They applied latent growth curve modelling / growth mixture modelling for statistical analysis]. They presented graphs distinguishing three sub-groups that follow distinct pathways across the 4 years. 25% of trans youth in their study were identified as a ‘consistently low’ group who had low levels of anxiety/depression/risk-taking behaviours at baseline who continued to have low levels of anxiety/depression/risk-taking behaviours. 56% were classified as having ‘declining’ levels of anxiety/depression and consistently low levels of risk-taking behaviours, with levels of anxiety and depression slightly above a clinical diagnosis at baseline, later declining to slightly below clinical thresholds. 18% were categorised as elevated, having persistently high levels of anxiety/depression/risk-taking behaviours at baseline and later in study.

From further data analysis they discovered:

95% of youth who accessed early affirmative care were in the categories of consistently low (53%) and ‘declining’ levels of mental health problems, with only 5% of these youth in the category of having persistently high levels of anxiety/depression/risk-taking behaviours.

[Talking about ‘low’ and ‘declining’ as positive descriptors in a study on mental health at times feels a little counter intuitive, given we think of high mental health, or improving mental health as a good thing, whereas here we want to see low and declining mental health problems).

The youth who had consistently good mental health, or improving mental health had the following characteristics in common:

Less loneliness

Less gender minority stress

Higher parental acceptance

Higher emotional support

The study highlights that provision of HRT is not a magic cure to the mental health challenges of trans youth who are isolated, unsupported and facing anti-trans hostility and gender minority stress inside and outside of their homes.

Among youth with high levels of anxiety/depression/risk-taking behaviours at baseline, those with higher levels of baseline parental support were more likely to see improvements in their mental health.

Protection from gender minority stress, reduced isolation, emotional and social support, and parental support are all protective factors for trans youth mental health.

18% of the sample continued to have high levels of anxiety/depression/risk-taking behaviours throughout the study and this portion of trans youth would benefit from more targeted mental health support as well as support to reduce gender minority stress and isolation.

Next Dr Laura Kuper (they/them) presented preliminary findings of 5 – 8 year outcomes of the trans youth longitudinal survey. The study began in 2014 including annual youth and parent report surveys. It looked at quality of life, anxiety, depression, body dissatisfaction. Recently added new measures of gender dysphoria, socio-political stress and decision regret scale.

Wider study now includes 738 youth. At baseline ages 6-18 (mean 15), 64% assigned female at birth, 34% assigned male at birth. A few youth are now in year 9 of the study, most are currently in years 2-7 of the study (new enrolments to the study are being added each year).

Presented data on 267 youth and 317 parents who completed survey on access to treatment. The study looked at those who had started and at some point stopped treatment with oestrogen or testosterone. [For this presentation exact numbers were not provided and the graphs were hard to read precisely so there is a likely margin of error in the percentages I’ve given below – you’ll need to wait for publication of the proper research for the accurate numbers]

10% of those who had ever started oestrogen had at some point stopped oestrogen. The reasons for stopping oestrogen were examined. 1 was because was satisfied with the changes and didn’t need further oestrogen; 2 experienced unwanted changes; 2 had a change in their experience or understanding of gender; 2 stopped due to difficulties accessing oestrogen; 1 for other reasons. Just under half who ever stopped taking oestrogen ended up re-starting taking oestrogen. Youth and parents were asked the question re starting taking oestrogen “It was the right decision”. Around 70% of youth strongly agreed, 5% agreed, 2% neither agreed nor disagreed, 2% strongly disagreed. 60% of parents strongly agreed, 20% agreed, 2% neither agreed nor disagreed, 2% strongly disagreed. Youth and parents were asked the question re starting taking oestrogen “I regret the choice that was made”, and “the choice did me/my child a lot of harm” with the same findings (vast majority strongly disagreed, with only around 2% strongly agreeing).

32% of those who had ever started testosterone had at some point stopped testosterone, significantly higher than the portion who ever stopped oestrogen. The reasons for stopping testosterone were examined. 16 were because were satisfied with the changes and didn’t need further testosterone; 8 experienced unwanted changes; 8 had a change in their experience or understanding of gender; 2 had legal barriers to access; 23 (the largest portion) stopped due to difficulties accessing testosterone; 19 for other reasons. Just under half who ever stopped taking testosterone ended up re-starting taking testosterone, with several going through multiple points of stopping and re-starting. Youth and parents were asked the question re starting taking testosterone “It was the right decision”. Around 154 of youth strongly agreed, 8 agreed, 2 neither agreed nor disagreed, 1 (hard to read graph) disagreed, 1 (hard to read graph) strongly disagreed. 145 parents strongly agreed, 32 agreed, 7 neither agreed nor disagreed, 2 disagreed, 3 or 4 (hard to read graph) strongly disagreed. Youth and parents were asked the question re starting taking testosterone “I regret the choice that was made”, and “the choice did me/my child a lot of harm” with the same findings (vast majority strongly disagreed, with only around 1% strongly agreeing).

Dr Kuper then moved on to present findings on a 5 year longitudinal study of trans youth receiving oestrogen or testosterone. The study currently includes data for 558 youth at baseline, 431 at year one follow up, 275 at year two follow up, 163 at year three, 115 at year 4, 59 at year 5. The declining numbers at later years of follow up is because new youth keep being recruited into the study (not linked to drop out). [They applied linear mixed effect modelling to the dataset for statistical analysis].

Graphs were presented showing a significant and steady decrease in body dissatisfaction over 5 years time for both those on oestrogen and those on testosterone (with the same pattern for both). A graph of depressive symptoms showed a steady decrease in depression scores over the 5 years. The slope and change in depression was similar for both those on oestrogen and those on testosterone, but with those on testosterone having slightly higher depression at baseline and at current measure than those on oestrogen. Both groups were over the point for mild depression and near the level for moderate depression at baseline, and fell to at or just over the point for mild depression at current measure. Graphs showed some improvements in anxiety over time. Quality of life scores improved steadily over time for both groups.

Overall conclusions were:

Strong satisfaction with decision to receive treatment from youth and parents

Large improvements in body dissatisfaction, seen as the primary goal of treatment

Modest improvements in mental health and quality of life, which were also impacted by gender minority stress. They noted that this sample is in Texas where there are very significant socio-political stressors and state persecution, which is likely impacting on mental health measures.

This research also underscores the unsuitability of having mental health improvements as a key justifier for gender affirmative healthcare – especially for those youth who (through social support) have low levels of mental health at the start of puberty. Those youth do not see improvements in mental health, they see their good levels of mental health retained through medical transition. Reviews like the Cass review critiqued affirmative healthcare for not showing puberty blockers not having a significant enough boost to mental health – this is clearly the wrong variable to be tracking.   

Next Dr Kristina Olson presented on trans youth satisfaction with care. She presented existing knowledge on youth satisfaction with care, including the high levels of continuity of care, with the assumption that trans youth would not continue to take active efforts to continue healthcare that they did not want to continue. Also low rates of detransition to live as cis amongst trans youth who commence gender affirming healthcare. We also know there are cases of detransition / dissatisfaction, whilst noting that these two concepts are different and distinct.

This new study aimed to assess levels of satisfaction and regret following puberty blockers and HRT, and to assess continuity of care. Looked at trans youth project, more than 300 socially transitioned binary trans youth recruited between ages of 3 and 12 in years 2013-2017. Mostly US trans youth with some Canadians. Youth followed up every 1-2 years. Study has now been ongoing for 7 – 11 years. Youth have answered questions on average 3.8 times, and parents have answered questions on average 5.8 times. This study presents data from 2023 questionnaires, given to all youth who are currently 12+ and to one parent.

On average the cohort had socially transitioned at 6-7 years old. On average they had started blockers 5 years before the survey, at 11 years old. On average they had begun HRT 3.5 years before the survey, at 13 years old. This cohort, supported in childhood, has had good levels of mental health throughout childhood and into adolescence, with slightly elevated anxiety, matching well-being of cisgender peers.

269 were aged 12+ and had started gender affirming medical care and were eligible for this survey. 220 or 82% completed the survey. For the 18% who did not fill in this specific survey, the research team do have continuity of care medical records. Where data is provided by a youth and their parent, the data tables only show the youth report. Where youth data is not available, the parent reported data is provided.

215 reported on their experience with puberty blockers (160 direct from youth and 55 from parental report). Satisfaction was rated from 1 not at all happy to 7 extremely happy. Satisfaction was rated 6.4 average for youth and 6.7 average from parents. Regret was rated from 1 no regret to 7 strong regret. Regret was 1.5 for youth and 1.3 for parents.

170 reported on their experience with oestrogen or testosteone (119 direct from youth and 51 from parental report). Satisfaction was rated 6.5 average for youth and 6.9 average from parents. Regret was 1.4 for youth and 1.0 for parents.

Very high levels of satisfaction and very low levels of regret

Also asked participants if they would have preferred to receive healthcare treatment at a different time, with options: ‘wish earlier’, ‘correct age’, ‘wish later’, ‘wish never’. 2% of youth wished never to have received puberty blockers, 2% wished to have never received hormones, 1 parent in the sample wished never to have received puberty blockers. 18% of youth (4% parents) wished they had received puberty blockers earlier and 74% youth (86% parents) felt they had received them at the right time (in a sample receiving puberty blockers at average age 11). 34% of youth (19% parents) wished they had received oestrogen or testosterone earlier and 53% youth (75% parents) felt they had received them at the right time (in a sample starting oestrogen or testosterone at average age 13 years old.

From the overall sample, 97% have continued to access gender affirming medical care to this day. 2% have stopped accessing gender affirming medical care.

Overall – very high levels of satisfaction, very low rates of regret,

Only 9 individuals out of 220 sample (4%) experienced regret. 8 (3.6%) experienced regret for blockers, 3 (1%) experienced regret for hormones. From these 9 2 individuals (1%) expressed regret for both blockers and hormones. 4 of the nine stopped all treatment, 1 in the process of stopping treatment, 4 have continued to take blockers or hormones. From the nine expressing regret, about half regret ever starting treatment, about half regret a specific side effect or complication or regret not skipping straight to hormones without time on just blocker.

A majority of youth continue to express high satisfaction with care many years later. This cohort seems to align closely with their cisgender peers on mental health, well-being, and on rates of change of gender identity. Important to note that the access to gender affirming medical care that has accompanied this cohort, is harder to access today for their younger peers, with increasing barriers to trans healthcare across and beyond the USA.

Next Dr Marijn Arnoldussen from the Netherlands. The presentation was titled “gender related and psychological outcomes in adulthood after early gender related medical transition in adolescence”. Studies from the Netherlands tend be of interest, because they were an early supporter of a limited form of gender affirming care, with puberty blockers prescribed to a 13 year old trans boy starting in 1988, and with decades of follow up studies. Studies from the Netherlands also come with some significant baggage, in a highly controlled and potentially pathologizing and psychologically invasive model of care, where folks were expected to conform to a very defined stereotype of trans-ness to receive care. The narrowness of the model of expected transness has relevance to some of their outcomes. Knowing the UK children’s GIDS model sought to replicate the Dutch model, and knowing very closely just how abusive, invasive and harmful the UK approach to trans children has been, makes me approach data from the Dutch clinic with a significant degree of concern, especially where clinicians report data without asking centring the views of their patients, or where clinical control, coercion and pathologisation is apparent.

 The study aim was to describe long term gender outcomes, treatment regret, reflections on gender related medical care, and psychological outcomes for trans adults who received gender affirming medical care, including puberty blockers, during adolescence. The study focused on trans adults who took puberty blockers during adolescence and who started gender affirming hormones over 9 years ago. 145 service users were eligible, of whom 72 participated. This is clearly a pretty high drop out rate. In the UK service, high drop out rates are sometimes an indication of service users not having confidence in clinical research.

From the 72 participants, 51 (71%) were transgender men, 20 (28%) were transgender women. 1 (1%) non-binary. The binary focus of the cohort is perhaps unsurprising if, as was certainly the case in UK children’s clinics, non-binary transitions were not supported or permitted. Interesting that this  cohort who started medical transition in adolescence a decade ago, has significantly more trans men than trans women – when this phenomenon is noted in current youth it is blamed on tiktok which clearly did not exist a decade ago. This cohort started puberty blockers at an average age of 14.85 (range 11.47-17.97) and hormones at an average of 16.67 (range 13.93-18.46) and are followed up at average age 29.1 (range 25-36.29 year old). The oldest in this cohort are 36 years old. Hardly new treatment.  

94.4% had not experienced any change in their gender identity over time from starting blockers at  average age 14 to now being on average 29 years old.

83% (60 people) had not experienced any regret or doubt about their gender affirming medical.

17% (12 people) had experienced some form of doubt or regret – however:

For 2 people (3%) this was occasional thoughts what their life would be like if they hadn’t had medical transition, doubts rather than regrets.

3 people (4%) regretted the chosen surgical technique in genital surgery

4 people (5.6%) regretted either genital surgery or surgery to remove reproductive organs. This figure in particular need to be considered against two important realities – one, stating a desire for ‘full’ transition was in many places considered a key eligibility criteria for any form of medical transition, closing down possibilities for a less binary transition pathway, and two in the Netherlands until very recently surgical transition was deemed necessary for eligibility to change your legal gender and to access various state protections or rights as a trans person. I would assume that where there is pressure to engage in surgical transition, incidents of regret is arguably more likely.

2 people (2.8%) regretted becoming infertile and being unable to preserve sex cells

1 person regretted the hormones and surgery they received.

From the 72 patients followed into average age 29, only one stated a regret of hormones.

The cohort were asked about their ability to make decisions in adolescence. A significant majority, 50 people (69.4%) felt they were capable to make decisions at an even younger age then they were permitted to do under the Dutch model (where they received blockers at average age 14 and hormones at average age 16). 17 people (23.6%) felt they were at the right age for their decisions. 5 people (6.9%) felt they were too young, with these people particularly mentioning the impact on their fertility.

Overall, 98.6% of people were satisfied with their social and medical transition overall. 15% had some doubts or regrets, with this particularly related to aspects of surgical transition. 1 person regretted hormones and surgery. 93% felt, on reflection, they were capable to take decisions on medical transition during adolescence.

Finally in this session there was a presentation from Dr van der Meulen from the Netherlands entitled “sexual dysfunction after early endocrine treatment: long-term study in transgender adults”.

This session had elements of exoticisation and pathologisation of trans people that I found uncomfortable. I’ll share some of the results here. A study on 70 trans adults, comparing those who medically transitioned in early puberty (tanner 2 or 3) with those who medically transitioned in later puberty (tanner 4+). They were average age 29 during this research. For the 50 trans masculine participants, 18% medically transitioned in early puberty, for the 20 trans feminine participants 40% transitioned in early puberty.  

Amongst the groups of adult participants (average age 29), they were asked about experiences of sexual disfunction. For trans men 18% reported a problem with low sexual desire (80% reported no problem with sexual desire), and low sexual desire was reported for 22% of those who transitioned in early puberty compared to 17% for those who transitioned in late puberty. 16% of trans men reported too much sexual desire (64% reported no problem with too much sexual desire) and too much sexual desire was reported for 11% of those who transitioned in early puberty compared to 17% for those who transitioned in late puberty. 4% of trans men reported low sexual arousal (96% reported no problem with sexual arousal) and low sexual arousal was reported for 11% of those who transitioned in early puberty compared to 2% for those who transitioned in late puberty.; 24% reported difficulty orgasm (74% reported no problem orgasm) and difficulty to orgasm was reported for 33% of those who transitioned in early puberty compared to 22% for those who transitioned in late puberty.

For trans women 20% reported a problem with low sexual desire (60% reported no problem with sexual desire), and low sexual desire was reported for 38% of those who transitioned in early puberty compared to 33% for those who transitioned in late puberty. 0% of trans women reported too much sexual desire (100% reported no problem with too much sexual desire). 20% of trans women reported a problem with low sexual arousal (65% reported no problem with sexual arousal) and low sexual arousal was reported for 0% of those who transitioned in early puberty compared to 33% for those who transitioned in late puberty.; 35% reported difficulty orgasm (65% reported no problem orgasm) and difficulty to orgasm was reported for 0% of those who transitioned in early puberty compared to 58% for those who transitioned in late puberty.

Overall sexual disfunction was relatively low amongst these trans adults who medically transitioned in adolescence. There was no significant difference in sexual disfunction between those who medically transition in early puberty compared to those who sexually transition in late puberty. [Research on this topic surely, SURELY needs to better centre the voices and priorities of trans adults, and the multiple factors beyond early or late medical transition that likely impact on experiences – and surely some comparison to cis people’s experiences of sexual disfunction would make such research somewhat less exoticising and othering…]

A few follow up questions were held. One questioner stressed the importance of timeliness of publication of all the above new data – especially in contexts where healthcare is under attack. Another questioner asked about the mental health of neurodivergent populations, asking if datasets could be considered to see where autistic youth fitted on the mental health trajectories, noting the greater mental health challenges and [Is there a term like gender minority stress that applies to the stresses of navigating a neurotypical world?] that are carried by autistic youth that will not be ameliorated by gender affirmative care. There was also some discussion on what outcome indicators are best to track to monitor the impacts of gender affirmative healthcare, with panelists commenting that a narrow focus on mental health is probably not the right indicator.

I didn’t share any of my own research this time at WPATH, but given the WPATH content was very significantly dominated by US and Dutch research, I’ll end by sharing my contributions to the literature on puberty blockers here:

“I Didn’t Want Him to Disappear” Parental Decision-Making on Access to Puberty Blockers for Trans Early Adolescents – available here.

Experiences of puberty and puberty blockers: Insights from trans children, trans adolescents, and their parents – available here.

WPATH 2024

At the end of 4 days of trans health presentations from researchers, clinicians and community advocates from across (parts of) the world, I wanted to capture some of my key learnings and reflections. The conference took place the last week of September, in Lisbon, Portugal. This is my first WPATH (a conference of the World Professional Association for Transgender Health). A majority of trans communities have no access to WPATH information, yet WPATH learning is important to many trans people and families. I’ve always appreciated those (especially Ruth Pearce) who try to make conference information available to those unable to attend. I note the significant barriers to attendance for those without an employer or institution to fund expensive attendance fees and travel, to those with disabilities or caring responsibilities unable to travel, for those without a visa to come to Europe, to those facing other barriers to attendance.

Overall vibe

The overall vibe was better than I had expected, although my expectations were drawn from hearing really poor experiences at past WPATH conferences. I found overall the tone of trans positivity, depathologisation, treating trans people as equals, centring research and healthcare ethics, was better than I had expected. However, there were still a portion of content and conversations where biases were clearly on display. I particularly noticed these biases in the very frequent exclusion of non-binary existence, on the continued pathologisation, mistreatment and exoticisation of trans children, and on a very significant domination of a US and white perspective, with notably limited representation from global majority populations. I gather only 3 attendees were from Africa (out of 1,445 registered in-person attendees). I also am scratching my head to think if there was even a solitary reference to the experiences of trans children in care in the presentations I attended – I don’t think there was.

The event had a trans chill out room where trans attendees could step away from the main event to decompress and reflect. It was noticeable that few trans attendees spent time there in the first days of the conference, with the fullness of the room growing over time, as trans researchers, clinicians and advocates encountered more challenging content and interactions. On the third day I heard one person reflect that despite WPATH improvements, it is noticeable just how many trans people are sat in the trans space burnt out by negative engagements by day three of four. I myself had a number of negative and hostile encounters, and a number of presentations that I could not sit through, finding some content taxing or upsetting, particularly where content demonstrated abusive clinical or research practices towards trans children. There were a number of other challenges at the conference, with no encouragement of sharing pronouns (apparently pronoun ribbons were lost in shipping), not being able to find gender neutral toilets on the first evening, and apparently some staff policing of toilet usage which was rather surprising in a trans health conference.

There were also a large number of encounters and presentations that were an absolute delight. I met a huge number of people from across different countries and disciplines who deeply care for improving equality and justice for trans people of all ages and situations. I heard some research that shows where we should be in terms of ensuring research and healthcare is centring the rights and needs of trans communities. One clear highlight was an opportunity to connect with TPATH, the trans professional association for transgender health, including an opportunity to connect with some Portuguese trans folks who were not able to attend the conference.

 Session structure

 The session included plenary speeches, symposia, oral abstracts and posters. I will write about each in turn.

Plenary sessions.

On each day there were two plenary sessions, that were hour long speeches to the full audience, from one or two speakers, with a moderator. The plenary speakers were appointed by the WPATH president. Three were related to surgery, which I won’t engage with here as its not an area I focus on or know a lot about. A broader reflection was that at times the plenaries overall were a source of pathologisation, erasure of non-binary people, dehumanisation, exoticisation, and demonstration of clinical control over trans communities. There were several sessions where, if one had a bingo card of common areas of biases and indicators of cis-supremacy, one might have ticked off many exemplars. The speakers also privileged a white, cis, US/European, abled, and clinical position. Of the plenary sessions, the one I enjoyed the most was the opening plenary, delivered capably by an American, the US state representative for Montana, Zooey Zephyr. It was a powerful and moving speech, capturing the challenges that we currently face. I particularly resonated by the words (that I am paraphrasing), that when anti-trans laws are passed, when communities face state persecution, the harm comes severe and fast, whilst processes to overturn such harms are drawn-out and slow. Those words certainly resonated with my experience in the UK, where the harms of recent criminalisation of adolescent healthcare has indeed been severe and fast. The speech and presentation was excellent, but very US centred for an opening plenary. I wouldn’t expect anything less than US centred content from a US state representative, so this US centring is more a question for WPATH leadership than for the presenter. Why would a WPATH opening plenary would be so US centred. The tendency for WPATH (the World association) to act as US-path on holiday does appear to continue to be on display. However, this opening plenary was at least very strongly trans-positive, centring trans rights, calling attention to the abuse, control and persecution of trans communities, including trans children. The other plenaries alas did not all maintain this important commitment on trans-positivity, rights and justice. Several centred a clinical perspective grounded in assumptions of clinician control over trans lives. The plenary on trans children was particularly problematic and disappointing, presenting to a wide audience some older concepts and research that are problematic and outdated, centring and justifying clinical control over trans children. There were times across the plenaries where trans community and service user voice and perspectives were absent, with speakers prioritising a cis, adult, white, global North, clinician perspective. 

I was disappointed to have the plenary on puberty blockers delivered by stakeholder from the Dutch clinics, whose model does not centre trans child and adolescent rights. The presentation itself summarised older research (some of which is problematic) and failed to update the audience on newer research findings from other countries. It was a really lost opportunity to update general attendees on the most up-to-date research on puberty blockers. I also wish we could hear more from Dutch trans communities and service users, particularly child service users, on the Dutch approach. My own research has centred the experiences of service users in the English Children’s Gender Service, which aimed to replicate the Dutch model. My own experience and my research with that service has demonstrated widespread clinical abuse and harms to trans children in that service. (My research, including on experiences in gender clinics, experiences of childhood social transition, experiences with puberty blockers, and on pathologisation and cis-supremacy in healthcare can all be found here).

I hope the next WPATH can better centre child rights, trans rights, an ethics of depathologisation and equality in future plenary sessions, ensuring that any presentations from clinicians centre some fairly basic ethical commitments.

Parallel sessions

Across the conference there were 14 different sessions (hour long time slots), during which attendees had to choose between 5 parallel options, 3 of which were usually symposia and 2 of which were oral abstract sessions. That meant there were a total of 70 hour long sessions, that we could attend only 14 of. The sessions we could attend are recorded and available to watch on catch-up, and I’ll certainly check in on some of the ones I missed in coming weeks. Here I’ll comment on some of the symposia of oral abstract sessions that I attended.

Symposia

On being a target

There was an excellent session on trans researchers being a target of hate and harassment. Unsurprisingly it featured two UK researchers, talking about the amount of targeted hate that comes with being a trans researcher in the UK. We need to find better ways of supporting trans researchers. And we need our institutions to step up, both to protect trans researchers from external abuse, and to ensure research spaces and universities are actually safe from organised transphobia.

Trauma-informed approaches to care

This session talked about trauma informed approaches. I’ve not heard much discussion of this before, and certainly not on how to ensure child and adolescent care is trauma informed. I noted particularly the discussion on how certain mindfulness techniques are inappropriate and triggering rather than relaxing for those living with trauma. I recognised this in myself (I find mindfulness unbearable), but wasn’t aware this was a more general phenomenon. There has been a big recent focus on mindfulness in schools in the UK, and I wonder how this is being experienced by children living with trauma, which will include a lot of trans children.

Evolution of gender expression care

This session focused on the support that trans people, and especially younger trans children, may benefit from in areas of their life not related to medical care. The presenters are including the term ‘gender expression’ care to capture support with social transition, gender expression and finding gender joy, as distinct from and running parallel to medical transition support.

New long-term research on adolescent gender-affirming medical care

This session was excellent, with three important presentations from the US, from Diane Chen, Laura Kuper and Kristina Olson. I will write up some more detail on these three presentations soon as they are very timely and relevant. This is now written up as a separate blog post here.

Preserving evidence-based trans healthcare for adolescents in Europe and North America

This included presentations on how clinicians are navigating care restrictions and challenges to care. It included a focus on the UK, USA, Croatia, as well as discussion on upcoming guidelines from Switzerland, Germany and Austria. It included discussions of clinical care on the defensive, and how to ensure services that are under attack are shifted to the most defensible positions. I would have liked a more significant focus on how to ensure ethical principles and child rights within services that are under attack. I would have liked more explicit discussion of the impacts on trans children of a shift into defensive practice, which often includes bringing in or maintaining approaches that are not in a child’s best interest. I would have liked more consideration of how to ensure child rights and prioritised while operating under defensive practice, and more explicit acknowledgement of the harms, and more proactive work to ameliorate such harms. I’d also like more discussion of how a shift to defensive practice can provide a cover for coercive and harmful practices beyond what might be 100% essential. And how those shifting to defensive practice need to be more rather than less accountable to criticism of their practices. We also need to consider whether shifting to the most defensible positions actually appeases or reduces criticism from trans-hostile actors – in the UK this was certainly not the case, every shift to the defensive led to more attacks on care. I think a ethical and rights based defense of care is stronger than any effort at appeasement. (This session clashed with another session on “Research-based, ethical, lifesaving: findings from a long-term satisfaction study on pediatric gender affirming care” that I hope to catch up on later.

Centring Gender Diverse Young Children’s Voices and Experiences in Clinical Care and Research

A tool developed by Zucker (1977) was presented, with discussion of its cisnormative flaws and failings. The presentation then talked about experience of modern research using this tool. I don’t understand using an outdated and inappropriate tool developed by Zucker with modern trans children. I didn’t stay for the full presentation so perhaps I misunderstood something. I worry about research practices that do not centre trans children’s well-being and do not protect from research related harms. In my experience every question asked to a trans child by a professional, of any type, is an example of that child being treated differently. Children notice when their identity is treated differently. They notice when they are being studied. All research needs to consider the potential for children feeling shame. I returned to the session later for a discussion on the use of dolls to help children display their gender. I was probably not in the best head space for the doll discussion. Again, I was prompted to ask myself how many cis children are asked to dress a doll in a meaningful outfit under adult stranger/professional scrutiny. How do those trans children feel. I’m sure this can be done in a really positive way, and I don’t doubt the researchers presenting who seemed lovely do this in a positive way. But there was also suggestion of sharing this approach and these dolls much more widely. I didn’t stay for the whole session. I hope there was also significant discussion on the many trans children who do not want to dress dolls while under adult scrutiny, on the children who don’t want to be treated differently just because they are trans. I hope there was discussion on the ways in which a doll dressing exercise can be done really badly by the wrong facilitator, how it could be experienced by a child as being a subject of adult curiousity of how different and weird they are compared to their siblings and peers who are not asked to do this task. I worry about any initiative that en masse treats trans children in a different way to cis children, and anything that is not individually determined and centred. The younger children who I have known most closely would have hated being asked to dress a doll to present themselves, especially at a point in time early in transition where their clothing and expression is being most extremely scrutinised and judged and commented on by those around them. For all of these tools, I guess the context and the intent is really important. In a really safe environment, where children are not already feeling hostility and judgement and shame, perhaps a doll dressing challenge could be a source of gender joy for some children. How do we know which environments are safe for this? How do we know which children will enjoy it? How do we offer this as one of very many, many, fun activities, and ensure children do not feel compelled to engage as part of defending their existence to the adults around them. Given the choice of a coordinated doll dressing activity and a game of tag or watching a movie, a majority of the trans kids I know best would choose tag or watching a movie. In my experience, younger trans children, especially those early in transition, are very very tuned in to any areas of their life where they are treated differently or scrutinised. How do we ensure that activities that treat them differently do not make them feel like there are being judged or assessed, or make them feel they need to perform to meet adult expectation or approval.

Oral abstracts

Engaging Family

There were several presentations on engaging with families. It is interesting to see the work that is being done with families who help them to better understand and support their trans children. One reflection that I had, was on how can support services better recognise a diversity of support needs amongst parents.

From my own experience I wonder about the targeting. In my experience the parents and carers who show up, who are reachable with interventions, are less likely to benefit from basic trans 101 education and support with things like ‘ambiguous loss’. As a trans person and a parent in such spaces, I have found some ‘support’ to be really upsetting, and I know plenty of cis parents who have felt the same – who have needed support in managing state oppression and the minority stress of being a family facing overt anti trans abuse and hate, who have found sessions focused on ambiguous loss or trans 101 a world away from the support that they actually need.

On the topic of ambiguous loss I also wonder how we can better recognise the way in which rhetorics of ambiguous loss provide some parents with a cushion that enables them to gain emotional support from trans-ignorant cis communities – for that parent, moving away from a rhetoric of ambiguous loss also means moving away from their available emotional support network. That support network needs to be replaced by a trans-positive support network, and I’d really be interested in seeing how support for parents can focus less on trans 101 or on dealing with ambiguous loss, and more on building trans positive emotional support networks, reducing the isolation of supportive parents/carers, and on providing meaningful support to help families facing state persecution, helping parent/carers emotionally stay afloat whilst engaging in constant advocacy for child rights and whilst facing harassment, isolation and abuse.

Especially in context where oppression is high and rising, I would love to see more focus on how to ensure supportive parents and carers can not fall apart under the strain. Of course, the trans-hostile and trans ignorant parents are also very important – I would just not assume that they are the parents who will voluntarily walk through the door. Unless you have other means of reaching such parents (eg direct referral from the GP, or targeted outreach with a less supportive parent building on a connection with a more supportive parent), I wouldn’t assume you are ever meeting those parents.     

I would also like to see more consideration within those facilitating and organising parent/carer support groups of how to ensure the spaces do not expose parents/carers to an excessive amount of anti-trans opinion. In my experience those spaces work best when they are a good mix of parents who have become strongly supportive and educated, who are actively fighting for trans children’s rights and those parents who are new and managing their own learning curve. I have noted a tendency for the facilitation of these spaces to have shifted towards younger, non-parent and trans facilitators. I have also noted a growth in space for parents to discuss at length their own transphobic assumptions, where facilitators perhaps want every parent to have their say and don’t feel able to police any minimum standards of respect. The last ‘support’ group I attended I was directly called a ‘traitor to feminism’ for being a non-binary person in a facilitated group discussion without any backup.

(as well as being a toxic work environment for a younger trans facilitator) this ‘let everyone speak their mind’ approach is also driving away those parents who are more supportive. The cis parents who are attending in search of a safe space away from a trans-hostile world are encountering yet more trans hostility in those facilitated support spaces, and many are stopping attending. I myself more often than not find such spaces traumatising rather than reinvigorating, and I know many cis parents who feel the same. If the more supportive parents, who are looking for support on trans advocacy and dealing with transphobia get deterred from support groups, then that is a huge loss to those new parents who usually learn a lot of trans positivity and how to better support their children from parents who have walked the same path. I would be interested to hear more research that recognises the diversity of positionality within parents groups (including the existence of trans parents in those spaces), how to ensure those spaces are overall safe spaces for all parents (whilst providing some space for parents sharing their worries), and a mechanisms for more targeted approaches where a trans 101 isn’t the starting point for all families, with an emphasis on the support required beyond trans 101.

I always find the topic of ‘ambiguous loss’ a bit triggering. Clearly some parents do experience it, and need some therapeutic support with it. I wish there was more recognition of the diversity of ambiguous loss. In my experience a majority of parents experience ambiguous loss, which when you dig deeper is about a loss of safety. Especially for white families in countries and areas not particularly affected by violence or conflict, parents have an expectation of safety for their child. When they realise their child is trans, parents can have a reaction of fear, that their child is not going to be safe, in the present or in the future. This loss of expected safety is something that parents can find emotionally upsetting. In a world where there isn’t much language, parents can fall to a language of ‘grief’ to explain this loss. For some parents who I know, the language of grief is a mis-application, describing something that is different to grief. I’d like to see more focus on loss of safety as a concept, including helping parents to re-examine and re-conceptualise what they are feeling, especially where their feelings are not really about grief.

Clearly some parents also feel something like grief. One presenter mentioned an initiative on creative writing to help parents process their emotions. They included a description of a parent writing a eulogy. I am not a counsellor and don’t know how best to help parents who feel that way. I do worry about how much acceptance or space we should give for a grief narrative in more general or plenary spaces. It is clearly offensive. I also worry about the impact of giving space to a grief narrative on those parents and carers who have actually lost a child. Parent support spaces should be a safe space for those parents too, and I think more care should be taken over how ‘ambiguous loss’ is dealt with, including ensuring there are spaces for parents who want to talk about a loss of safety without having to hear other parents talk about ‘grief’ for a still alive child.

Law, Policy and Ethics

This included a presentation on the reasons why a proposed NHS research trial on puberty blockers is unethical, as well as evidence on the negative impacts of US healthcare bans.

Community engagement

This was a fantastic session, centring trans led research including from India, centring trans-led community designed research, the roles of community initiatives in steering research or clinical practice, and the importance of gaining service user trust.

Other conversations

I had many other interesting conversations. In many countries it was shocking to me to hear just how very far ahead of the UK in terms of treatment and support for trans children and adolescents they are. Folks from many countries expressed concern and solidarity on just how bad the UK is right now, seeing it as so very far behind acceptable levels of care, law and policy. I heard about interesting upcoming work, about current practice in the US, Canada, Australia, New Zealand, about support for trans youth in countries like South Africa and Vietnam, about upcoming research on disassociation, about initiatives to support folks under state violence. I met many awesome people who I hope to stay in touch with.

Ban on social transition is cruel and anti-science

In December 2023, the UK government released school’s guidance, proposing restrictions on social transition, including a complete ban on social transition at primary school.

The guidance is non-statutory, meaning schools do not need to follow it. Indeed, leaked civil service legal advice revealed that even government lawyers recognise the guidance as likely to be illegal, and likely to fail when it will be challenged in court. Any school considering following this guidance needs to know that their actions will likely be found unlawful when challenged in court.

Here I want to outline the reasons the guidance is not just cruel, but also anti-science. I will focus on one aspect of the guidance, the proposed restrictions on social transition, and the proposed ban on social transition at primary school. I am well-qualified to write on this topic, having focused my entire PhD on researching the experiences of trans children and families who socially transitioned at primary school in the UK, and being myself a parent of a trans child who similarly socially transitioned at primary school.

The guidance claims to be an effort to address ideology, but it is very clear that the guidance is entirely driven by anti-trans ideology, rather than by evidence, science, or indeed by listening to the experiences of those with lived experience of being or supporting a trans child.

Last week I published my 14th peer reviewed article on the topic of trans children. Within science and evidence based policy-making, peer review in credible journals is a vital part of assessing evidence, ensuring our decisions are based on the best available evidence. My latest peer reviewed article analyses and synthesises all existing studies on the topic of social transition. It examines them in detail, clarifying what evidence underpins their conclusion. Within all modern (post 2013) literature, evidence concludes that social transition is either beneficial, or neutral. The vast majority of studies conclude that social transition is beneficial for trans children. Just two studies conclude that social transition is neutral, neither beneficial nor harmful. My latest article examines one of those two studies, highlighting a wide range of limitations that undermine its stated conclusions.

The latest government guidance states that social transition is not neutral, raising the suggestion that it is either beneficial or harmful. If they looked to the evidence they can see that there is zero modern (post 2013) evidence that social transition is harmful, and multiple studies, of multiple types (qualitative, quantitative, retrospective), from multiple countries (UK, USA, Spain) demonstrating that social transition is beneficial, indeed critical for trans children’s well-being, self-esteem and happiness.

Claims that social transition is harmful are supported by the most pathetically flimsy of evidence, comprised of two main strands.

One flimsy strand of evidence used by opponents of social transition, looks to a 2011 published study of 2 Dutch girls, who changed their gender expression (wore trousers or cut their hair short) and then regretted changing their clothing and haircut due to the bullying that ensued. Neither child asked to be seen as a boy, neither child changed pronoun. There was no social transition in this study, nor is it clear that the children in question were even trans. I wrote about this back in 2017. The 2011 study on two girls who never socially transitioned was used by WPATH in their standards of care version 7 (published in 2013) to caution against social transition, guidance that has caused uncalculated harm across the world. (This poor science from 2011 also made it to version 8 of the standards of care).

You cannot tell me that 2023 social policy on social transition should be governed by a 13+ year old study of two children, neither of whom socially transitioned, or even asked to socially transition. The fact this same study is influencing gov guidance in 2023, ignoring all the continually growing body of modern evidence that social transition is vital and life-saving, is beyond belief.

The second flimsy strand of evidence used by opponents of social transition, argues that it is social transition itself that makes children remain trans. It argues that support for social transition somehow changes a child’s future trajectory, keeping children trans who would otherwise escape into a life of cis normality. The evidence for this claim of social transition ‘concretising’ identity is entirely speculative. Anti-trans voices look to the high degree of consistency in trans children in 2023, where a majority (but not all) of socially transitioned trans children continue to identify as trans into adolescence and adulthood. They compare this with studies from the 1950s-2000s, where children in gender clinics did not commonly identify as trans in adolescence. There is one humungous problem with this pet theory. Gender clinics in the 1950s-2000s did not focus on trans children at all. Instead they focused on boys who were deemed excessively and problematically feminine, boys who were referred to by research study leaders as ‘sissy’ or ‘proto-gay’. Clinics were not focused on trans children at all, instead they were focused on making feminine boys ‘man-up’, lest they become either gay or trans in the future. A scholar who experienced such gender clinics as a boy, who has written about the deep harm the experience had on him, is now a gay man. He wrote how conversion therapy at gender clinics left him feeling that there was something deeply wrong with him, that he was unacceptable for being gender non-conforming. These older abusive studies should in no way guide modern practice for two reasons. One, they did not focus on trans children. Indeed, one analysis from this cohort claimed, without no self-awareness, that they had deducted that a good way of distinguishing the children who would grow up to be a trans woman from those who would grow up to be a gay man was to actually ask them, whether they were a girl, with the majority i) not identifying as a girl and ii) not growing up to be a trans woman. Almost like researchers need to actually listen to those whose lives they seek to understand! The second reason to discount the findings from these earlier studies conducted from the 1950s onwards, is that there were deeply abusive and coercive sites of conversion therapy, a practice now recognised as abusive and harmful.

Literature conducted in the modern era in fact reveals the opposite conclusion to that speculated by anti-trans actors. A study by Olson et al concluded that social transition did not concretise identity, but was in fact a consequence of the children who felt most strongly and consistently being most likely to be supported to social transition.

All modern (post 2011) studies on social transition shows either neutral or positive impacts. The vast majority of studies show overwhelmingly positive impacts of social transition. The only two studies that show neutral impacts, were situated in gender clinics and have significant study limitations, including not bothering to actually ask the children in question for their views.

Positive benefits concluded by a majority of studies on the topic include reduced anxiety, reduced depression, increased self-worth, reduced suicidal ideation, reduced suicidal behaviour, improved mood, increased confidence, increased happiness.

Trans children have a right to their identity. They have a right to health, happiness, equality. They have a right to social transition. Denying a child’s social transition is oppressive, abusive and harmful.

For more detail, please do click on this article here:

The importance of child voice in trans health research: a critical review of research on social transition and well-being in trans children

Please see these articles on experiences of social transition:

“Euphoria”: Trans children and experiences of prepubertal social transition

“I never wanted her to feel shame”: parent reflections on supporting a transgender child

Read this research on the harms of denying social transition

“I Was Losing That Sense of Her Being Happy”—Trans Children and Delaying Social Transition

And these articles on trans children’s experiences at school:

Gender minority stress in education: Protecting trans children’s mental health in UK schools

Institutional cisnormativity and educational injustice: Trans children’s experiences in primary and early secondary education in the UK

Thriving or Surviving? Raising Our Ambition for Trans Children in Primary and Secondary Schools

Trans children have a right to a safe and happy childhood. Trans children have a right to social transition.

You can respond to the government’s abusive proposal here